Index. Note: Page numbers of article titles are in boldface type.

Transcription

1 Cardiol Clin 24 (2006) Index Note: Page numbers of article titles are in boldface type. A Abciximab in PCI, ACE trial, 182 Actinomycin D-eluting stent, 224 ACUITY trial, 190 Acute myocardial infarction volume-related outcomes in cardiac catheterization laboratory and, ADMIRAL trial, 182 ADVANCE trial, 184 American College of Cardiology/American Heart Association recommendations for coronary intravascular ultrasound, American College of Cardiology/American Heart Association task force on lesion morphology, , 155 AMIGO trial, 203 Angina CABG vs. percutaneous coronary interventions for, Angiography quantitative coronary Angioplasty balloon cutting, 205 FXminiRAIL, 206 excimer laser coronary, 206 AngioSculpt scoring balloon, Angio-Seal closure device, 281, 282 ANTHEM-TIMI trial, 191 Anticoagulant(s) in PCI, direct thrombin inhibitors, LMWH, UFH, Antiplatelet agents in PCI, 186 abciximab, aspirin, eptifibatide, platelet ADP receptor antagonists, platelet glycoproteiniib/iiia receptor antagonists, 180 tirofiban, Antithrombotic therapy in PCI, See also specific agents, e.g., Antiplatelet agents, in PCI. anticoagulants, antiplatelet agents, 186 clinical trials of, acronyms for trial names, fondaparinux, novel agents, ARMYDA-2 trial, 179 Artery(ies) anatomy of normal, 163 ASPIRE trial, Aspirin in PCI, Atherectomy, directional coronary, rotational, Atherosclerosis described, 201 treatment of PCI related, Atherotomy, /06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi: /s (06) cardiology.theclinics.com

2 300 INDEX B Balloon angioplasty cutting, 205 FXminiRAIL, 206 BAT trial, 190 Biolimus A-9-eluting stent, 224 C CABG. See Coronary artery bypass grafting (CABG). CACHET trial, 190 CADILLAC trial, 182 CAPTURE trial, 181 Cardiac catheterization laboratory quality in described, 287 identification of, 287 quality management in volume-related outcomes related to, acute myocardial infarction experience with, current experience with, described, 288 longitudinal studies, PTCA and, 289 surgical experience with, CHARISMA trial, 180 Chito-Seal pad in vascular closure, 278 Chronic total coronary occlusions (CTOs), histopathology of, 248 treatment of indications for, non-guidewire novel devices in, 251 outcomes of, 252 patient selection for, 248 techniques in, 251 CLASSICS trial, 177 Clopidogrel in PCI, Closure devices vascular, See also Vascular closure devices. Coronary angiography quantitative Coronary angioplasty excimer laser, 206 Coronary artery(ies) left main evaluation of intravascular ultrasound in, 165 Coronary artery bypass grafting (CABG), 255 percutaneous coronary interventions vs. implications in patient management, 262 in angina patients, randomized trials comparing limitations of, stenting vs., Coronary bifurcation lesions, anatomic classification of, guiding catheter in selection of, 236 impossible side branch access, isolated ostial lesions involving mail vessel or side branch, 233 of main vessel, 234 of side branch, stents for crush technique, culottes technique, future directions in, implantation of lesion preparation for, number of, one stent by intention to treat, pharmacotherapy with, 244 reverse crush technique, 242 simultaneous kissing stents technique, T technique, 242 two stents by intention to treat, 237 V stent technique, 237 Y technique, 243 Coronary occlusion total, 157 CREDO trial, 177, 180 CRUISE trial, 188 C-SIRIUS trial, 219 CTOs. See Chronic total coronary occlusions (CTOs).

3 INDEX 301 CURE trial, 177, 178 Cutting balloon angioplasty, 205 D Debulking devices, Degenerated saphenous vein grafts, DESIRE trial, 203 Direct thrombin inhibitors in PCI, Directional coronary atherectomy, DISPERSE-2 phase II trial, Distal protection devices, Doppler ultrasound intracoronary 161 Drug-eluting stents, cost-effectiveness of, 226 durable polymer, paclitaxel-eluting stents, failed or minimally effective, ongoing programs, outstanding issues related to, restenosis after predictors of, 226 sirolimus-eluting stents, thrombosis related to, D-Stat products in vascular closure, 278 Duett closure device, E EDRES trial, 204 Endeavor trials, 223 EPIC trial, 181 EPILOG trial, , 188 EPISTENT trial, 181, 186, 188 Eptifibatide in PCI, E-SIRIUS trial, 218 ESPRIT trial, 183, 186 Everolimus-eluting durable polymer stent, 224 Excimer laser coronary angioplasty, 206 F FANTASTIC study, 177 FFR. See Fractional flow reserve (FFR). Fondaparinux in PCI, Fractional flow reserve (FFR) in lesion severity evaluation, 161 FXminiRAIL balloon angioplasty, 206 H HELVETICA trial, 189 Heparin(s) LMWH in PCI, UFH in PCI, HORIZONS trial, 190 I IABP. See Intra-aortic balloon pump (IABP). IMPACT-II trial, 183 Impella CardioSystems, complications of, contraindications to, 272 described, 6 7 hemodynamic effects of, 273 implantation of, INTERACT trial, 188 Intra-aortic balloon pump (IABP), 266 Intracoronary ultrasound Doppler in lesion severity evaluation, Intravascular ultrasound American College of Cardiology/American Heart Association recommendations for, arterial measurements by, 163 complications of assessment of, for stent restenosis, 170 for stenting guidance, future of, in coronary lesion evaluation, in left main coronary artery evaluation, 165

4 302 INDEX Intravascular (continued) in percutaneous coronary interventions era, See also Percutaneous coronary interventions, intravascular ultrasound in era of. vulnerable plaque identification with, ISAR diabetes trial, 222 ISAR-2 trial, 182 ISAR-DESIRE trial, ISAR-REACT trial, 179, 182 ISAR-SWEET trial, 181 J JUMBO-TIMI 26 trial, 179 L Laser therapy, Left main coronary artery evaluation of intravascular ultrasound in, 165 Left ventricular assist devices (LVADs), See also specific types, e.g., TandemHeart IABP, 266 Impella CardioSystems, intra-aortic balloon pump, 266 TandemHeart, Lesion(s) angulated, 154 bifurcation, 154 calcification of, classification of, degenerated saphenous vein grafts, eccentric, 156 inaccessible, 156 irregular, 156 long, 156 morphology of American College of Cardiology/American Heart Association task force on, , 155 ostial, 157 severity of evaluation of, LMWH. See Low molecular weight heparin (LMWH). Low molecular weight heparin (LMWH) in PCI, LVADs. See Left ventricular assist devices (LVADs). M Myocardial infarction acute volume-related outcomes in cardiac catheterization laboratory and, N NICE-1 trial, 188 P Paclitaxel derivative-eluting polymeric sleeve, 225 Paclitaxel spray stents, Paclitaxel-eluting stents durable, polymer, PARAGON trials, 186 Patch(es) vascular closure related, PCI. See Percutaneous coronary interventions (PCIs). PCI-CURE trial, 180 Perclose Prostar in vascular closure, Percutaneous coronary interventions (PCIs), , See also specific types AngioSculpt scoring balloon, antithrombotic therapy in, See also specific agents, e.g., Antiplatelet agents, in PCI. atherectomy, atherotomy, CABG vs. implications in patient management, 262 in angina patients, randomized trials comparing limitations of, cutting balloon angioplasty, 205 debulking devices, directional coronary atherectomy, distal protection devices, excimer laser coronary angioplasty, 206 FXminiRAIL balloon angioplasty, 206 history of,

5 INDEX 303 intravascular ultrasound in era of, See also Intravascular ultrasound. laser therapy, LVADs, rotational atherectomy, SilverHawk System, thrombectomy devices, Percutaneous transluminal coronary angioplasty (PTCA) volume-related outcomes in cardiac catheterization laboratory and, 289 PISCES program, Platelet(s) biology of, 175 Platelet ADP receptor antagonists in PCI, Platelet glycoproteiniib/iiia receptor antagonists in PCI, 180 PRISM-PLUS trial, 184 PROXIMATE-TIMI 27 trial, 191 PTCA. See Percutaneous transluminal coronary angioplasty (PTCA). PURSUIT trial, 182 Q Quality management in cardiac catheterization laboratory volume-related outcomes related to, See also Cardiac catheterization laboratory, quality management in, volume-related outcomes related to. Quantitative coronary angiography R RAPPORT trial, 182 RAVEL trial, 218 REALITY trial, 222 REPLACE-1 trial, 190 REPLACE-2 trial, 190 RESTORE trial, 184 Rotational atherectomy, S Saphenous vein grafts degenerated, Scion Clo-Syr P.A.D. in vascular closure, 278 Sealant closure devices, 281 SilverHawk System, SIRIUS registries and subset analyses, SIRIUS trial, 218 Sirolimus-eluting stents, SIRTAX trial, 222 SPORT trial, 204 Staple-mediated closure device, STEEPLE trial, 188 Stent(s) actinomycin D-eluting, 224 Biolimus A-9-eluting, 224 drug-eluting, See also Drug-eluting stents. everolimus-eluting durable polymer, 224 for coronary bifurcation lesions, See also Coronary bifurcation lesions, stents for. paclitaxel spray, paclitaxel-eluting durable, polymer, restenosis of intravascular ultrasound for, 170 sirolimus-eluting, Stenting CABG vs., intravascular ultrasound in, Suture-mediated closure devices, 278 SYNERGY trial, 189 Syveck Patch in vascular closure, T TandemHeart, applications of, 270 complications of, contraindications to, 268 described, explantation of, 269 hemodynamic effects of, 269 implantation of, subsystems of, TARGET trial, 185 TAXI trial, 222

6 304 INDEX TandemHeart (continued) TAXUS registries and subset analyses, TAXUS-I trial, 220 TAXUS-II trial, 220 TAXUS-III trial, 220 TAXUS-IV trial, TAXUS-V trial, 221 TAXUS-VI trial, 221 Thienopyridine antiplatelet agents in PCI, Thrombectomy devices, Thrombin inhibitors direct in PCI, Thrombosis(es) drug-eluting stents and, Thrombus(i), Ticlopidine in PCI, 177 Tirofiban in PCI, Total coronary occlusion, 157 TRITON-TIMI 38 trial, 179 U UFH. See Unfractionated heparin (UFH). Ultrasound Doppler intracoronary in lesion severity evaluation, intravascular in percutaneous coronary interventions era, See also Intravascular ultrasound. Unfractionated heparin (UFH) in PCI, V Vascular closure devices, Angio-Seal, 281 complications associated with, 285 Duett, patches, Perclose Prostar, sealant closure devices, 281 staple-mediated, suture-mediated, 278 Vasoseal, 281, 283 X-Site suture, Vasoseal closure device, 281, 283 Vein grafts saphenous degenerated, X XaNADU-ACS trial, 191 X-Site suture closure device in vascular closure,